Izana intiates study assessing namilumab for COVID-19
It is hoped that anti-GM-CSF therapies such as namilumab might play an important role in preventing or reducing deterioration in COVID-19 patients
Read More
Tag: Izana
- Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
- Venner Shipley announces opening of new Bristol office
- AAX Biotech and Vascurie announce new neuro-oncology collaboration
- Nxera Pharma reports positive results from phase 3 insomnia trial in South Korea
- Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment
